Jain et al. (1994) reported a significant association between pre-diagnosis dietary β-carotene intake and prognosis in patients with breast cancer with estrogen receptor (ER+) or progesterone receptor (PR+) status, but not in those with ER- or PR-negative status [27]. Here, ESR1 is linked to breast cancer.